Employer profile
Apertor Pharmaceuticals
2 certified H-1B filings across 2 fiscal years.
Snapshot year
FY2023 filings
1
FY2023 median
$145k
Top role
Scientist Iii - Chemistry
1 filings · all-time
Top state
CA
2 filings · all-time
Pay distribution
How Apertor Pharmaceuticals pays, by fiscal year
Each box is the p25–p75 interquartile range; the heavy line is the median and the whiskers reach p10–p90. Base salary only — hover a year for its figures.
Year-over-year
How Apertor Pharmaceuticals hired across H-1B fiscal years. The small figure under each filings count is its change vs the prior FY.
| FY | Filings | Median $ |
|---|---|---|
| FY2026 | 10% | $180k |
| FY2023 | 1— | $145k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl II
150%
Lvl IV
150%
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Scientist Iii - Chemistry | 1 | $145k |
| Associate Director, Chemistry | 1 | $180k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| CA | 2 | $145k |
Related employers
Similar H-1B volume
Frequently asked questions
- How much does Apertor Pharmaceuticals pay H-1B workers?
- Apertor Pharmaceuticals's median certified H-1B base salary is $145k (FY2023), from 1 filings. See the full salary distribution and percentiles above.
- How many H-1B workers does Apertor Pharmaceuticals sponsor?
- Apertor Pharmaceuticals has 2 certified H-1B Labor Condition Applications on record (FY2023–FY2026).
- What jobs does Apertor Pharmaceuticals sponsor for H-1B?
- Apertor Pharmaceuticals's most-sponsored H-1B roles include Scientist Iii - Chemistry, Associate Director, Chemistry.
- Where does Apertor Pharmaceuticals hire H-1B workers?
- Apertor Pharmaceuticals's top H-1B worksite states are CA.
Calculate your H-1B lottery odds →orCheck out the insights →